| Interaction of aldehydes derived from lipid peroxidation and membrane proteins S Pizzimenti, E Ciamporcero, M Daga, P Pettazzoni, A Arcaro, ... Frontiers in physiology 4, 242, 2013 | 361 | 2013 |
| Drug delivery nanoparticles in skin cancers C Dianzani, GP Zara, G Maina, P Pettazzoni, S Pizzimenti, F Rossi, ... BioMed research international 2014 (1), 895986, 2014 | 183 | 2014 |
| Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer L Fontana, RM Adelaiye, AL Rastelli, KM Miles, E Ciamporcero, ... Oncotarget 4 (12), 2451, 2013 | 149 | 2013 |
| Role of 4-hydroxynonenal-protein adducts in human diseases G Barrera, S Pizzimenti, ES Ciamporcero, M Daga, C Ullio, A Arcaro, ... Antioxidants & redox signaling 22 (18), 1681-1702, 2015 | 133 | 2015 |
| YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage E Ciamporcero, H Shen, S Ramakrishnan, S Yu Ku, S Chintala, L Shen, ... Oncogene 35 (12), 1541-1553, 2016 | 127 | 2016 |
| Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models E Ciamporcero, KM Miles, R Adelaiye, S Ramakrishnan, L Shen, SY Ku, ... Molecular cancer therapeutics 14 (1), 101-110, 2015 | 108 | 2015 |
| Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models L Shen, A Sundstedt, M Ciesielski, KM Miles, M Celander, R Adelaiye, ... Cancer immunology research 3 (2), 136-148, 2015 | 101 | 2015 |
| Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells R Minelli, R Cavalli, L Ellis, P Pettazzoni, F Trotta, E Ciamporcero, ... European journal of pharmaceutical sciences 47 (4), 686-694, 2012 | 89 | 2012 |
| GSH-targeted nanosponges increase doxorubicin-induced toxicity “in vitro” and “in vivo” in cancer cells with high antioxidant defenses M Daga, C Ullio, M Argenziano, C Dianzani, R Cavalli, F Trotta, C Ferretti, ... Free Radical Biology and Medicine 97, 24-37, 2016 | 87 | 2016 |
| EZH2 modifies sunitinib resistance in renal cell carcinoma by kinome reprogramming R Adelaiye-Ogala, J Budka, NP Damayanti, J Arrington, M Ferris, CC Hsu, ... Cancer research 77 (23), 6651-6666, 2017 | 73 | 2017 |
| Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications R Adelaiye, E Ciamporcero, KM Miles, P Sotomayor, J Bard, M Tsompana, ... Molecular cancer therapeutics 14 (2), 513-522, 2015 | 70 | 2015 |
| Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer E Ciamporcero, M Daga, S Pizzimenti, A Roetto, C Dianzani, ... Free Radical Biology and Medicine 115, 447-457, 2018 | 69 | 2018 |
| Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts KM Miles, M Seshadri, E Ciamporcero, R Adelaiye, B Gillard, ... PloS one 9 (11), e112371, 2014 | 66 | 2014 |
| Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells P Pettazzoni, S Pizzimenti, C Toaldo, P Sotomayor, L Tagliavacca, S Liu, ... Free Radical Biology and Medicine 50 (2), 313-322, 2011 | 64 | 2011 |
| HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma S Ramakrishnan, SY Ku, E Ciamporcero, KM Miles, K Attwood, S Chintala, ... BMC cancer 16, 1-15, 2016 | 55 | 2016 |
| Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells P Pettazzoni, E Ciamporcero, C Medana, S Pizzimenti, F Dal Bello, ... Free Radical Biology and Medicine 51 (8), 1610-1618, 2011 | 36 | 2011 |
| Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts L Wei, S Chintala, E Ciamporcero, S Ramakrishnan, M Elbanna, J Wang, ... Oncotarget 7 (47), 76374, 2016 | 35 | 2016 |
| Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cells A Cerbone, C Toaldo, R Minelli, E Ciamporcero, S Pizzimenti, ... PLoS One 7 (6), e40149, 2012 | 31 | 2012 |
| PPARγ in coronary atherosclerosis: in vivo expression pattern and correlations with hyperlipidemic status and statin treatment A Pucci, L Formato, M Muscio, E Brscic, S Pizzimenti, F Ferroni, ... Atherosclerosis 218 (2), 479-485, 2011 | 31 | 2011 |
| AS601245, an anti‐inflammatory JNK inhibitor, and Clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile in CaCo‐2 colon … A Cerbone, C Toaldo, S Pizzimenti, P Pettazzoni, C Dianzani, R Minelli, ... PPAR research 2012 (1), 269751, 2012 | 30 | 2012 |
